Founder And President
CurrentLloyd Technologies, Inc. develops medical disinfection technologies to help fight Hospital Acquired Infections (HAI's) and Multi-Drug Resistant Organisms (MDRO's). We have been developing better disinfection technology solutions since 2015, well before COVID-19, when we started developing novel UV disinfection technologies for occupied environments, with two granted patents (US 10,195,300 and US 10,639,390) and other patent pending inventions. We will soon be introducing a new family of patent-pending innovations focused on reducing Catheter Associated Urinary Tract Infections (CAUTI's) and other catheter induced illnesses and injuries. We are also developing a novel solution to help reduce "forever chemicals" in the environment, including PFAS, “Gen-X,” Persistent Organic Pollutants, etc., for which we were awarded US patent 11,512,013. Our technologies are available for license or co-development with suitable partners.